Pinealon

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) belonging to the family of short peptide bioregulators developed within Russian gerontology research, often associated with the work of Khavinson and colleagues.

It is used as a laboratory research tool and is studied among the shorter peptide bioregulators for its reported activity in neural and cellular experimental systems.

It is popularly associated in nootropic and longevity communities with reputed neuroprotection and support for cognitive aging and brain health.

Pinealon is a short peptide bioregulator that researchers are investigating for its purported neuroprotective properties, including interest in oxidative-stress protection and neuronal resilience relevant to cognitive aging.

It is anecdotally reported in biohacking and nootropic circles to support mental clarity, memory, and brain-health markers, making it a frequently discussed peptide for healthy neurological aging.

These are areas of active or preclinical investigation and community interest, not outcomes established in humans.

In rodent-model and cell-culture research, investigators have examined Pinealon in relation to neuroprotection markers, oxidative-stress responses, and gene-expression changes in neural tissue.

These findings are laboratory observations describing measured cellular responses in experimental models, not outcomes demonstrated in humans.

Pinealon is provided as a lyophilized powder and is stored at -20°C in a sealed container, protected from light and humidity.

For research applications it is reconstituted with bacteriostatic or sterile water and kept at 4°C for short periods, or aliquoted and frozen at -80°C for extended storage. Each batch is supplied with an HPLC certificate of analysis.